| XSPRAY PHARMA AB |
| Schweden |
| Gesundheit |
| SE0009973563 / A2H48J |
| 6XP (Frankfurt) |
| FRA:6XP, ETR:6XP, 6XP:GR |
| - |
| https://xspraypharma.com/ |
|
Xspray Pharma AB (publ) is a Sweden-based pharmaceutical company specializing in the development of innovative amorphous product candidates using its patented HyNap technology platform. The company focuses on creating improved versions of marketed pr..
>Volltext.. |
| 122.26 Mio. EUR |
| 121.77 Mio. EUR |
| - |
| -14.65 Mio. EUR |
| -16.07 Mio. EUR |
| -0.42 EUR |
| 13.91 Mio. EUR |
| 14.41 Mio. EUR |
| -18.11 Mio. EUR |
| 7.1 |
| - |
| 39.95% |
| - |
| - |
| - |
| - |
| XSPRAY |
| 05.04.26 |
|